Orchard Financial Statements From 2010 to 2024

ORTXDelisted Stock  USD 5.27  0.01  0.19%   
Orchard Therapeutics financial statements provide useful quarterly and yearly information to potential Orchard Therapeutics PLC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Orchard Therapeutics financial statements helps investors assess Orchard Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Orchard Therapeutics' valuation are summarized below:
Orchard Therapeutics PLC does not presently have any trending fundamental ratios for analysis.
Check Orchard Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orchard Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Orchard financial statements analysis is a perfect complement when working with Orchard Therapeutics Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Orchard Therapeutics PLC Company Return On Equity Analysis

Orchard Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Orchard Therapeutics Return On Equity

    
  -0.72  
Most of Orchard Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orchard Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Orchard Therapeutics PLC has a Return On Equity of -0.7151. This is 97.02% lower than that of the Biotechnology sector and 98.04% lower than that of the Health Care industry. The return on equity for all United States stocks is 130.68% higher than that of the company.

Orchard Therapeutics PLC Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orchard Therapeutics's current stock value. Our valuation model uses many indicators to compare Orchard Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orchard Therapeutics competition to find correlations between indicators driving Orchard Therapeutics's intrinsic value. More Info.
Orchard Therapeutics PLC is rated below average in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orchard Therapeutics' earnings, one of the primary drivers of an investment's value.

About Orchard Therapeutics Financial Statements

Orchard Therapeutics investors use historical fundamental indicators, such as Orchard Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orchard Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. Orchard Therapeutics is traded on NASDAQ Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Orchard Stock

If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges